Can personalized use of NSAIDs be a reality in the clinic?

Research output: Contribution to journalArticleAcademicpeer-review


The use of NSAIDs in rheumatology could be improved by an appropriate risk scoring system that accounts for adverse events such as bleeding and thrombosis. Such a risk score has now been developed using data from the PRECISION trial, but is this score ready to be applied in clinical practice?
Original languageEnglish
Pages (from-to)387-388
JournalNature Reviews Rheumatology
Issue number7
Publication statusPublished - 1 Jul 2019

Cite this